Title | Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Bick AG, Popadin K, Thorball CW, Uddin MMesbah, Zanni MV, Yu B, Cavassini M, Rauch A, Tarr P, Schmid P, Bernasconi E, Günthard HF, Libby P, Boerwinkle E, McLaren PJ, Ballantyne CM, Grinspoon S, Natarajan P, Fellay J |
Corporate Authors | Swiss HIV Cohort Study |
Journal | Sci Rep |
Volume | 12 |
Issue | 1 |
Pagination | 577 |
Date Published | 2022 01 12 |
ISSN | 2045-2322 |
Keywords | Adult, Case-Control Studies, Clonal Hematopoiesis, Female, HIV Infections, Humans, Male, Middle Aged, Prospective Studies |
Abstract | People living with human immunodeficiency virus (PLWH) have significantly increased risk for cardiovascular disease in part due to inflammation and immune dysregulation. Clonal hematopoiesis of indeterminate potential (CHIP), the age-related acquisition and expansion of hematopoietic stem cells due to leukemogenic driver mutations, increases risk for both hematologic malignancy and coronary artery disease (CAD). Since increased inflammation is hypothesized to be both a cause and consequence of CHIP, we hypothesized that PLWH have a greater prevalence of CHIP. We searched for CHIP in multi-ethnic cases from the Swiss HIV Cohort Study (SHCS, n = 600) and controls from the Atherosclerosis Risk in the Communities study (ARIC, n = 8111) from blood DNA-derived exome sequences. We observed that HIV is associated with a twofold increase in CHIP prevalence, both in the whole study population and in a subset of 230 cases and 1002 matched controls selected by propensity matching to control for demographic imbalances (SHCS 7%, ARIC 3%, p = 0.005). We also observed that ASXL1 is the most commonly mutated CHIP-associated gene in PLWH. Our results suggest that CHIP may contribute to the excess cardiovascular risk observed in PLWH. |
DOI | 10.1038/s41598-021-04308-2 |
Alternate Journal | Sci Rep |
PubMed ID | 35022435 |
PubMed Central ID | PMC8755790 |
Grant List | R01 HL148565 / HL / NHLBI NIH HHS / United States HHSN268201700001I / HL / NHLBI NIH HHS / United States HHSN268201700004I / HL / NHLBI NIH HHS / United States P30 DK040561 / DK / NIDDK NIH HHS / United States U01 HL123336 / HL / NHLBI NIH HHS / United States HHSN268201700002I / HL / NHLBI NIH HHS / United States HHSN268201700005I / HL / NHLBI NIH HHS / United States R01 HL151283 / HL / NHLBI NIH HHS / United States R01 HL148050 / HL / NHLBI NIH HHS / United States DP5 OD029586 / OD / NIH HHS / United States R01 HL086694 / HL / NHLBI NIH HHS / United States U54 HG003273 / HG / NHGRI NIH HHS / United States HHSN268201700003I / HL / NHLBI NIH HHS / United States |